- Product Details
Keywords
- PNU-282987
- PNU282987
- PNU 282987
Quick Details
- ProName: PNU-282987
- CasNo: 123464-89-1
- Molecular Formula: C14H17ClN2O
- Appearance: Solid powder
- Application: Use as research only
- DeliveryTime: in stock
- PackAge: according to the clients requirement
- Port: Tianjin
- ProductionCapacity: 10 Kilogram/Month
- Purity: More than 98%
- Storage: Store at -20°C
- Transportation: by sea or by air
- LimitNum: 500 Milligram
- Valid Period: 2 years
Superiority
1.we are direct manufacturer and we have 7 years experience in this aera.
2.we can provide competitive price for every customer and guarantee the quality of our goods.
3.Specials are possible when client's order is big enough, including the discount policy;
4.we promise we will return your money if our product don't have effect.
5.Our company promise to deliver clients' package to his hands safely, or we'll cover the total loss and reship in time;
6. Our customers may buy our products again after they use our sample.
In stock ,>98% purity with low price. If you need HNMR\HPLC,please contact us!
Details
PNU-282987 is a highly selective α7 nAChR agonist (Ki = 26 nM) displaying negligible blockade of α1β1γδ and α3β4 nAChRs (IC50 ≥ 60 μM). PNU-282987 is inactive against a panel of 32 receptors at 1 μM, except 5-HT3 receptors (Ki = 930 nM).
Tianjin Kailiqi Biopharma Technology Co., Ltd, is a professional manufacturer specialized in the production and distribution of active pharmaceutical ingredients and intermediates. Our company has strong R&D ability and production experience to provide the customers new APIs. We specialize in developing innovative processes for the synthesis of a wide range of products. We also undertake custom synthesis and contract manufacturing.if you are interest in,pls contact with me,we also have Lab,specifical in some hard synthesis.